4
Changes in Ownership
GYRE THERAPEUTICS, INC. Filed Acc 0001209191-22-010407
President & CEO bought 3,250 shares at $0.46 ($1,495)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| USMAN NASSIM President & CEO | 2022-02-09 | Purchase | +3,250 | $0.46 | $1,495 | 21,291 | D: show line 1 in the form |
| Open-market purchases · 3,250 sh · avg $0.46 · $1,495 | |||||||
Loading xslF345X03/doc4.xml…